Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.
暂无分享,去创建一个
[1] K. Tanikawa,et al. Vitronectin in liver disorders: Biochemical and immunohistochemical studies , 1992, Hepatology.
[2] D. Jenne,et al. Structure of Vitronectin and its Biological Role in Haemostasis , 1991, Thrombosis and Haemostasis.
[3] R J Falk,et al. Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. , 1991, The Journal of investigative dermatology.
[4] S. Bhakdi,et al. [Functions and relevance of the terminal complement sequence]. , 1990, Immunitat und Infektion.
[5] K. Preissner,et al. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. , 1989, Blood.
[6] B. Dahlbäck,et al. Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. , 1989, The Journal of investigative dermatology.
[7] Fibronectins and Vitronectin , 1989, The Lancet.
[8] T. Mollnes,et al. S‐Protein Is Synthesized by Human Monocytes and Macrophages in Vitro , 1989, Scandinavian journal of immunology.
[9] K. Preissner,et al. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. , 1988, Clinical and experimental immunology.
[10] D. Mosher,et al. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. , 1988, Blood.
[11] S. Katayama,et al. Three types of vitronectin in human blood. , 1988, Cell structure and function.
[12] K. Preissner,et al. S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3 , 1987, European journal of haematology.
[13] K. Yamada,et al. Immunological characterization of human vitronectin and its binding to glycosaminoglycans. , 1986, Journal of biochemistry.
[14] B. Dahlbäck,et al. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. , 1986, The Journal of biological chemistry.
[15] K. Preissner,et al. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin. , 1986, European journal of biochemistry.
[16] D. Jenne,et al. Molecular cloning of S‐protein, a link between complement, coagulation and cell‐substrate adhesion. , 1985, The EMBO journal.
[17] K. Preissner,et al. Physicochemical characterization of human S-protein and its function in the blood coagulation system. , 1985, The Biochemical journal.
[18] E. Ruoslahti,et al. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[19] B. Dahlbäck,et al. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. , 1985, Biochemistry.
[20] D. Jenne,et al. Monoclonal antibodies to human plasma Protein X alias complement S-protein , 1985, Bioscience reports.
[21] T. Foley,et al. Quantitation of spreading factor in human biologic fluids. , 1984, The Journal of laboratory and clinical medicine.
[22] E. Ruoslahti,et al. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Engvall,et al. Cell attachment on replicas of SDS polyacrylamide gels reveals two adhesive plasma proteins , 1982, The Journal of cell biology.
[24] K. Stenn,et al. Epibolin: a protein of human plasma that supports epithelial cell movement. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Heldin,et al. Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor. , 1981, Science.
[26] H. Müller-Eberhard,et al. Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. , 1979, The Journal of biological chemistry.
[27] L. Fryklund,et al. Primary structure of somatomedin B A growth hormone‐dependent serum factor with protease inhibiting activity , 1978, FEBS letters.
[28] R. Holmes. PREPARATION FROM HUMAN SERUM OF AN ALPHA-ONE PROTEIN WHICH INDUCES THE IMMEDIATE GROWTH OF UNADAPTED CELLS IN VITRO , 1967, The Journal of cell biology.
[29] W. Sun,et al. Polymorphism of vitronectin. , 1989, Blood.
[30] E. Ruoslahti. Fibronectin and its receptors. , 1988, Annual review of biochemistry.
[31] K. Miyazaki,et al. The culture of human tumor cells in serum-free medium. , 1981, Methods in enzymology.